Key result
Key clinical trials underpinning the approval of ticagrelor contain uncovered inaccuracies that raise fresh concerns regarding their overall data integrity.
Answers are grounded in this paper and cite their sources.
This investigative report raises concerns regarding the integrity of the pivotal clinical trials for ticagrelor.
As generic versions of AstraZeneca’s blockbuster drug ticagrelor prepare to enter the market, The BMJ raises fresh concerns over the integrity of the clinical trials that underpinned its approval. Peter Doshi reports
No takes yet. Share an insight, caveat, or question.
Peter Doshi (2025) studied this question. Key clinical trials underpinning the approval of ticagrelor contain uncovered inaccuracies that raise fresh concerns regarding their overall data integrity.
Synapse has enriched 10 related papers. Consider them for comparative context: